Maven Capital Partners (Maven), has invested a further GBP500,000 in GENinCode, a genetic testing company specialising in the risk assessment and prediction of cardiovascular disease.
Element Ventures launches USD130 million founder-backed fund to invest in future leaders in B2B financial technology
Element Ventures, one of Europe’s leading B2B fintech-focused venture capital firms, has launched a USD130 million fund to invest in the founders building tomorrow’s financial enterprise technology businesses.
Vala Capital has invested in three fast-growth start-ups with sustainable strategies after successfully completing its first funding round for its new Sustainable Growth EIS. The company plans to raise GBP15 million for the sustainable EIS over the next two years and, having raised its target of GBP1.2 million for the first round, is due to embark on a second round of fundraising in September.
Just one quarter of venture capital went to early stage “true venture” businesses in 2020, says Price Bailey
Just one quarter of venture capital funding went to early stage “true venture” businesses in 2020, according to an analysis undertaken by Price Bailey, a Top 30 firm of accountants.
EmergeVest, a Hong Kong-based growth-oriented private equity investment group, has invested in Lucy, a neobank focused on women entrepreneurs, through seed funding. In addition, Dr Jessica Bruser of EmergeVest has joined Lucy’s board of directors.
Segulah Medical Acceleration AB (SMA) has invested in UK-based Signifier Medical Technologies’ USD35 million Series D convertible financing.
O’Melveny has advised Spectro Cloud, a next-generation Kubernetes enterprise management platform, in in the completion of a USD20 million Series A funding. The financing round was led by Stripes, a prominent investor in software and consumer products.
Cold Bore Technology has closed USD14 million in a growth financing round led by bp ventures with participation from the Canadian Business Growth Fund (CBGF).
Topas Therapeutics GmbH (Topas), a private biotechnology company developing immune tolerance-inducing drugs to treat and potentially cure a variety of autoimmune diseases, today announced that the Company has successfully extended its Series B round with an additional EUR18 million (~USD22 million) raised, bringing the total for this financing to EUR40 million. All of Topas’ existing investors participated in the extension.
Secured Finance, a platform provider for the cryptocurrency loans and derivatives market, has raised USD4.0 million in its oversubscribed seed funding round.